Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)

Background: Several recent randomized therapeutic exploratory trials demonstrated improvement of progression-free survival and in some even overall survival using stereotactic body radiotherapy in patients with oligometastatic disease. However, only very few patients enrolled in these trials had bre...

Full description

Bibliographic Details
Main Authors: David Krug, Reinhard Vonthein, Alicia Illen, Denise Olbrich, Jörg Barkhausen, Julia Richter, Wolfram Klapper, Claudia Schmalz, Achim Rody, Nicolai Maass, Dirk Bauerschlag, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Stereotactic body radiotherapy
Stereotactic ablative radiotherapy
Radiosurgery
Metastatic breast cancer
Quality of life
Progression-free survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000355

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000355

Similar Items